The Wilson Centre, a non-partisan policy forum, interviews Public Policy Scholar Eleonore Pauwels about the benefits and risks of human genome editing.

“The benefits are going to be tremendous and they are going to happen in our lifetime.” Eleonore Pauwels discusses breakthroughs in the process of editing the human genome, and in particular the role of CRISPR in this “exciting and terrifying” future of genome editing.

This interview is a great, in-depth analysis of the current state of play in human genome editing, examining what we can do, what we can’t do, and what we shouldn’t do. And in the current climate, where any experiment involving human germ line editing or cloning is highly unlikely to get federal funding or approval, what is the role of the private sector in shaping this discussion?

In a recent FLG poll 38% of people felt that germline editing was inevitable, while 34% felt that there was too much uncertainty to make definite statements. Let us know what you think: if human genome editing is inevitable, where do we draw the line between what is and is not acceptable? 

More on these topics